
Group 1 - Class Action Attorney Juan Monteverde's firm, Monteverde & Associates PC, is investigating Turnstone Biologics Corp. regarding its sale to XOMA Royalty Corporation, where existing shareholders will receive $0.34 in cash per share and one non-transferable contingent value right [1] - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1] - The firm operates from the Empire State Building in New York City and has a successful track record in trial and appellate courts, including the U.S. Supreme Court [2][3] Group 2 - The investigation raises questions about the fairness of the deal for existing Turnstone shareholders [1] - The firm offers free consultations for shareholders who have concerns or wish to obtain additional information [3]